Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e3182a99590
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Synthetic HIV-1 Matrix Protein P17-Based AT20-KLH Therapeutic Immunization in HIV-1-infected Patients Receiving Antiretroviral Treatment: A Phase I Safety and Immunogenicity Study

BMC Infectious Diseases
Infectious Diseases
2014English

Immunologic Activity and Safety of Autologous HIV RNA-electroporated Dendritic Cells in HIV-1 Infected Patients Receiving Antiretroviral Therapy

Clinical Immunology
AllergyImmunology
2010English

Clinical Relevance of Drug Interactions in HIV-Infected Patients Receiving Antiretroviral Therapy

2011English

Recurrent Pulmonary Sarcoidosis in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Improved Survival of HIV-1-Infected Patients With Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy

PLoS ONE
Multidisciplinary
2011English

Risk and Incidence of Pulmonary Diseases Among HIV-infected Patients in the Era of Combination Antiretroviral Therapy

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2011English

Immune Reconstitution Inflammatory Syndrome-Associated Burkitt Lymphoma After Combination Antiretroviral Therapy in HIV-Infected Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Responsiveness of the MOS-HIV and EQ-5D in HIV-infected Adults Receiving Antiretroviral Therapies

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2013English

Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy